News

WDIO News14h
Alzheimer’s Association weighs in on FDA approval of blood test to help diagnose
The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...
The Scientist10d
Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test
The Lumipulse pTau 217/ β-Amyloid 1-42 Plasma Ratio test uses Fujirebio’s fully automated LUMIPULSE® G1200 instrument system, ...
News-Medical.Net on MSN3d
Blood test pinpoints early Alzheimer’s risk with high accuracy
Researchers evaluated a fully automated plasma biomarker panel to detect early amyloid-β accumulation in cognitively ...
Medical Device Network on MSN11d
FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s
The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
FDA clears first blood test to reliably predict Alzheimer’s disease
The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s ...
FDA approves blood test to detect Alzheimer’s disease
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...
New blood test for Alzheimer's approved by FDA
The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...